BEGIN:VCALENDAR
VERSION:2.0
PRODID:icalendar-ruby
CALSCALE:GREGORIAN
X-WR-CALNAME:7th Annual International IP Summit
X-WR-TIMEZONE:Eastern Time (US & Canada)
BEGIN:VEVENT
DTSTAMP:20261018T033031Z
UID:tag:localist.com\,2008:EventInstance_47136155773891
DTSTART:20241024T153000Z
DTEND:20241024T230000Z
DESCRIPTION:Please join Boston College Law School and Ropes & Gray at the 7
 th Annual International IP Summit. The summit is a premier forum for pract
 itioners\, business leaders\, academics\, and government officials to expl
 ore the dramatically evolving global IP environment. You must register abo
 ve to attend. Speaker bios are available on the IP Summit website.\n\nKeyn
 ote Speaker: David Korn\n\nDavid Korn will discuss legislative and executi
 ve agency efforts to decrease drug prices\, including proposed patent refo
 rms\, Centers for Medicare and Medicaid direct negotiations on listed drug
  prices\, and the FTC's challenge to bio companies' listing of patents on 
 the Orange Book. He will discuss the potential effects of these efforts on
  the pharma and bio innovation ecosystems. \n\nKorn is Vice President\, In
 tellectual Property (IP) and Law\, for the Pharmaceutical Research and Man
 ufacturers of America (PhRMA). He focuses on IP issues in Congress\, the P
 atent and Trademark Office and other agencies\, as well as in amicus brief
 s in cases of interest to PhRMA. He has degrees in biomedical engineering 
 from Duke and Northwestern and a J.D. from Harvard Law School. Prior to jo
 ining PhRMA\, he worked in private practice and clerked in the U.S. Distri
 ct Court for the District of Delaware.\n\nOCTOBER 24: Day One Keynote and 
 Panels\n\nCheck-in will begin at 11:30 am\, with lunch and the keynote add
 ress at noon. This event is free and open to the public.\n\n11:30AM–12:0
 0 PM : Networking and Registration (with lunch)\n\n12:00–1:00 PM: Welcom
 e Remarks & Keynote Address (with lunch)\n\nSpeakers:\n\nWelcome with Odet
 te Lienau\, The Marianne D. Short\,. Esq.\, DeanFireside Chat with David K
 orn and Professor David Olson\n 1:10–2:10 PM: Panel 1: The Unified Paten
 t Court and Global Enforcement Strategy\n\nPanelists:\n\nCharles Larsen (M
 cDermott\, Will & Emery LLP\, Partner)Chris de Mauny (Bird & Bird LLP\, Ba
 rrister & Foreign Legal Consultant)Matt Shapiro (Ropes & Gray\, Counsel)Mo
 derated by Ed Kelly (Boston & Galway LLP\; Partner (retired)\, Ropes & Gra
 y)The UPC changes how companies consider global enforcement of patent righ
 ts.  The UPC seems to facilitate parallel litigations at the UPC and the U
 S Courts.  This can increase complexity of already complex disputes.  For 
 example\, issues of trade secret enforcement\, often part of a patent disp
 ute\, have to be evaluated carefully before bringing an action at the UPC\
 , as the UPC offers less discovery about protected technical information\,
  and applies different standards of privilege and confidentiality.\n\n2:15
 –3:15 PM: Panel 2: Leaky Models\, IP Ownership\, and Other Consideration
 s for AI Dealmaking and Licensing\n\nPanelists:\n\nBenjamin Brown (Onto In
 novation\, AGC\, Chief IP Counsel)Kati Pajak Strzelczyk (AI\, Innovation &
  Trust\, Commercial & Procurement\, Open Table/Kayak\, Counsel)Georgina Jo
 nes Suzuki (Ropes & Gray\, Counsel)Moderated by David Olson (BC Law profes
 sor\, former director of PIE)This panel will cover recent AI deal trends a
 nd key considerations for acquiring AI companies or AI-related technology\
 , including licensing considerations with respect to AI models and data. T
 he panel will also discuss important developments regarding IP ownership a
 s well as pending litigation related to AI. The discussion will be relevan
 t to private equity (PE) sponsors\, strategic acquirers\, and technology a
 nd life sciences companies looking to leverage AI to boost existing or dev
 eloping lines of business.\n\n3:15–3:45 PM: Networking Break\n\n3:45–4
 :45 PM: Panel 3: Bridging the Atlantic: Global AI Regulation in the UK\, E
 U\, US and China\n\nPanelists:\n\nHiba Hafiz (BC Law Professor\; Advisor t
 o Federal Trade Commission)Ed Machin (Ropes & Gray\, Counsel\, London)Dunc
 an Willson (USPTO IP Attaché at the US Embassy in Beijing\, 2018-2023)Mod
 erated by Kevin Powers (Director\, BC Law’s MLS in Cybersecurity Program
 )Regulations and guidelines are appearing globally that guide and limit th
 e way organizations can deploy and market AI systems and AI-powered tools.
  The White House has published an AI Bill of Rights\, the UK and EU have e
 ach set out the AI Act\, and China has announced Interim Administrative Me
 asures for Generative AI. These policy statements and proposed regulations
  address concerns of safety\, fairness and competition and seek to protect
  health\, reduce algorithmic discrimination\, regulate automated biometric
  surveillance and reduce unfair business practices. Other actors\, includi
 ng the US FTC and all major patent offices have taken up issues of AI as i
 t relates to their respective areas\, including fair business practices an
 d what constitutes an inventor and a copyrightable work.\n\n4:50–5:50 PM
 : Panel 4: China Strategies for Life Sciences Companies\, Research Univers
 ities and Institutes\, and Academic Medical Centers\n\nPanelists:\n\nNicho
 las Caezza (Butterfly Network\, Inc.\, VP\, Deputy General Counsel)David P
 eloquin (Ropes & Gray\, Partner)Dan Zheng (Takeda Pharmaceutical Company L
 imited\, Senior Director of Business Development)Moderated by David McInto
 sh (Ropes & Gray\, Partner)Bipartisan legislation\, including the proposed
  BIOSECURE Act and the recently-enacted Protecting Americans’ Data from 
 Foreign Adversaries Act\, as well as President Biden’s Executive Order o
 n Preventing Access to Americans’ Bulk Sensitive Personal Data by Countr
 ies of Concern\, could limit the ability of U.S. pharma companies\, univer
 sities\, research institutes and academic medical centers to contract with
  biotechnology companies with ties to “foreign adversaries\,” includin
 g the Chinese government\, or to engage in research that involves the shar
 ing of sensitive personal data or biospecimens of U.S. individuals with en
 tities located in “countries of concern\,” such as the People’s Repu
 blic of China.\n \nOur panelists will discuss the latest updates on recent
  legislation and rulemaking targeting China-based organizations. The conve
 rsation will also cover the global implications of these policies\, specif
 ically for life sciences companies\, research institutes and academic medi
 cal centers that use CROs and CMOs located in China or engage in research 
 collaborations involving China.\n\n5:50–5:55 PM: Closing Remarks\n\n6:00
 –7:00 PM: Networking & Cocktail Reception\n\n \n\nOCTOBER 25: Day Two Ro
 undtable Session \n\nThis Roundtable Session will feature an interactive d
 iscussion among participants focused on how recent laws\, regulations\, ec
 onomic changes\, and technological advancements have impacted deal making.
  Participants will be coming from a range of backgrounds and experiences. 
 During the session\, participants will have an opportunity to share their 
 views on current market trends\, emerging areas of risk and opportunity\, 
 and best practices. All participants are asked to attend the entire sessio
 n. Topics to be discussed will include:\n\nDeal Trends in Life Sciences an
 d AI (Private Equity\, Venture Investing\, etc.)The proposed BIOSECURE Act
  and its potential effects on the life sciences industry.The EU AI Act and
  other enacted and proposed laws regulating the development and use of AI.
 The CrowdStrike outage and cybersecurity and IT lessons learned.The Suprem
 e Court’s recent overturning of Chevron and how businesses and regulator
 y agencies are responding.For more information\, please contact lawevent@b
 c.edu.\n\nPlease note that the October 25 roundtable is by application/inv
 itation only. Please indicate your interest when registering for the Summi
 t.
GEO:42.343041;-71.193681
LOCATION:Boston College Law School/Newton Campus\, Lunch in Stuart Yellow R
 oom\, Event in EW 120\, Reception in Stuart 414
SUMMARY:7th Annual International IP Summit
URL;VALUE=URI:https://events.bc.edu/event/7th-annual-international-ip-summi
 t
CATEGORIES:Conference
END:VEVENT
END:VCALENDAR